Sanofi (Group) [since May 2011]

http://www.sanofi.com

Sanofi-aventis is the world's third largest pharmaceutical company, ranking number one in Europe. Backed by a world-class R&D organization, Sanofi-aventis is developing leading positions in seven major therapeutic areas: cardiovascular, thrombosis, oncology, metabolic diseases, central nervous system, internal medicine, and vaccines. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY). *

	Start	2011-05-06 renamed
	Predecessor	Sanofi-Aventis (Group)
	Industry	pharmaceutical

	Region	Paris
	Country	France
	Street	174 avenue de France
	City	75635 Paris
	Tel	+33-1-5377-4000
		Address record changed: 2012-01-11

Basic data	Employees	I: 50,001 to 100,0 (2005-12-31)
	Currency	EUR
	Annual sales	28,052,000,000 (sales, net, consolidated (2007) 2007-12-31)
	Profit	5,911,000,000 (2007-12-31)
	Cash	1,711,000,000 (2007-12-31)

		* Document for »About Section«: Innogenetics. (11/13/06). "Press Release: Sanofi-aventis, Innogenetics, and Inserm to Collaborate on Alzheimer’s Disease". Paris & Gent.

		Record changed: 2012-05-03

To subscribe to our free, monthly [MSC] Newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

NEW: Visit our brand new forthcoming web portals Life-Sciences-Germany.com and Life-Sciences-Europe.com

» top

Follow Us!

Top News

Upcoming Events

Associations

Partners

Sanofi (Group) [since May 2011]